Adawi, Deema Hilmi http://orcid.org/0009-0008-2281-2655
Fredj, Nadia Ben
Al-barghouthi, Ahmad
Dridi, Ichrack
Lubada, Mustafa
Manasra, Mohammad
Aouam, Karim
Article History
Accepted: 5 November 2023
First Online: 25 November 2023
Declarations
:
: D.A. was responsible for conceiving and designing the study, collecting the blood samples, performing data analysis, interpreting the data, and writing the manuscript; N.B. for critically revising the manuscript and contributing in writing the manuscript; A.A. for contributing in samples analysis HPLC method validation; I.D. for contributing in HPLC method validation and development for imatinib detection; M.L. for contributing in sample analysis and in HPLC method validation; M.M. for facilitating cooperation for patients hospital admission and following up patients; and K.A. for providing critical intellectual input, revising the manuscript, and contributing in writing the manuscript.
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: The data and materials used in this study are available upon reasonable request. Researchers interested in accessing the data and materials may contact Deema hilmi adawi at deema.hilmi.adawi@gmail.com.
: Not applicable.
: All procedures in this study were conducted in accordance with the 1964 Declaration of Helsinki and its later amendments. The study was approved by the Palestinian ministry of Health on 15 September 2021
: Informed consent was obtained from all study participants. They were informed about the nature of the study, its objectives, and the use of their data.
: Not applicable.